Mangaluru: Youth Congress protestors call Amit Shah a terrorist', court arrest

Mangaluru, Jun 29: As many as 49 fresh covid-19 cases were reported in Dakshina Kannada district in past 24 hours taking the district’s tally to 568.

At the same time 38 persons were also discharged from the hospital after complete recovery from covid 19.

Out of the 49 positive cases, 14 persons had returned from Saudi Arabia, UAE, and Qatar. 17 persons had contracted the disease from patient number 9590. 3 persons are suffering from an influenza-like illness (ILI), and 4 persons are suffering from Severe Acute Respiratory Infection.

The health officials are tracing the contacts of six others. All the 49 persons have been shifted to hospital for treatment. Most of them are said to be asymptomatic.

Bengaluru, May 10 The asymptomatic and healthy people among international passengers will now have to undergo institutional quarantine for 14 days, according to the new standard operating procedure (SoP) issued by the Karnataka government for a third time.

The SoP, which has been revised twice, was issued by the Health and Family Welfare Department on Saturday, May 9.

The international passengers will be divided into two categories upon their arrival at the airports. Symptomatic will be directly sent to the covid-19 hospitals. Asymptomatic will not be allowed to go home directly. They will be sent for mandatory quarantine for 14 days in hotels and guest houses. 

Earlier, international passengers had to undergo seven days of institutional and seven days of home quarantine.

Passengers will also be tested only twice — once on arrival and for the second time on the 14th day — instead of the earlier decision to test thrice. They will be discharged from the facility if they test negative.

The first group of 350 people are expected to arrive from London at 3 am on Monday at the Kempegowda International Airport, said Lakshman Reddy, Joint Director, Social Welfare Department. 

Flights are expected from Singapore on May 13, Jeddah on May 14 and San Francisco on May 15. 

Among the stranded include 4,408 tourists and visitors, 3,084 students, 2,784 migrants and 557 ship crew.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.